Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-002603-15Phase 2Active
Phase 2 trial of ganciclovir in cytomegalovirus disease (CMV) (2 arms), sponsored by INCLIVA Biomedical Research Institute. Primary endpoint: Virologic negative conversion in blood and tracheal aspirate at day 14. Started Sep 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-002603-15.